Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : JDS Uniphase (JDSU) -- Ignore unavailable to you. Want to Upgrade?

To: Lynn who wrote (3055)	12/16/1999 7:40:00 AM
From: Glenn McDougall	Respond to of 24042

Thursday, December 16, 1999 JDS buys itself a Christmas stocking stuffer By Kevin Bell, Ottawa Sun Acquisition-hungry JDS Uniphase Corp. swallowed another company yesterday, this time a small Nepean-based firm with just 25 employees. JDS did not disclose how much it paid for six-year-old Oprel Technologies, which develops fibre-optic signal amplifiers and test equipment for optical electronic devices. One analyst estimated the price to be around $10 million. JDS co-chairman Jozef Straus said Oprel will strengthen the company's growing line of products and improve the delivery time to market. Emil Savov, an analyst with Goepel McDermid Inc., said the acquisition is fairly small by JDS' standards but will help the firm stay ahead in the quickly-evolving fibre-optics business. "It's such a small company so it's difficult to say how important it is, but there's probably value in the technology," he said. "There's so much going on they need all the optical engineers they can find." JDS is trying to position itself as a large supplier of "complete solutions" to firms that are building large fibre-optic telecommunications networks, such as Nortel Networks and Lucent Technologies. "With Oprel, they're getting some interesting technology, but more importantly they're getting some expertise," Savov said. Last month, JDS bought U.K.-based Sifam Ltd. for $140 million and acquired Epitaxx Inc. of New Jersey in October for $400 million US.